Ministry of Justice
of the Azerbaijan Republic
 
 
 

Project

     A Project  “Strengthening  TB  control  in penitentiary  system of Azerbaijan” (AZE-910-G06-T) under  a Grant Agreement between the Ministry of Justice of the Republic of Azerbaijan and the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) has been found on October, 2010. The amount of this Project is 4 826 727 EUR. The Project  Phase I starting date is 1st of  November, 2010.
     The  Main  Medical  Department of the Ministry of Justice of the Republic of Azerbaijan is the Principal  Recipient  of  the  Grant and  the  program  is  implemented  by  Principal  and  Sub-recipient (“Support to Health” NGO). The Project Implementation Unit is responsible for implementation of the Global Fund  Round  9  Project. The overall  Goal of the Project  is to reduce  the burden of  Tuberculosis  infection  in Azerbaijan  Penitentiary system by scaling up the management and  prevention  the  further  infection  spread.
     The main objective of the Strengthening TB control project in prisons of Azerbaijan is programme management capacities building, monitoring and evaluation, ensuring quality diagnosis and treatment of all forms of TB with  patients  support and follow-up, operational research and regional collaboration.
 

The proposed activities are organised in the following categories: 

  1. Strengthening program management, monitoring and evaluation and capacity building for TB control in prisons;

  2. Improving diagnosis of TB including DR-TB;

  3. Provision of TB treatment with patient support and follow-up of released prisoners;

  4. Establishing  a Regional Knowledge Hub and Training Centre for TB control in prisons; and

  5. Conducting operational research on drug-resistant tuberculosis.

 

Target people: 

  • People detained in correctional facilities all over the country;
  • TB patients in the penitentiary sector; and
  • MDR TB patients in the penitentiary sector.
 

Program Indicators:

  1. MDR-TB prevalence among new smear positive cases (%) in the penitentiary sector.

  2. MDR-TB prevalence among previously treated smear positive cases (%) in the penitentiary sector.

  3. Case detection rate for new smear positive TB cases country-wide.

  4. Treatment success rate: new smear positive TB cases in the penitentiary sector.

  5. Treatment success rate of MDR-TB patients in the penitentiary sector.

  6. Interim treatment success rate of MDR-TB patients in the penitentiary sector.

  7. Treatment success rate: new smear positive TB cases country-wide.

  8. Percentage and number of smear positive pulmonary TB patients reported among TB suspects registered during a specified time period in the penitentiary sector.

  9. Percentage and number of new and retreatment TB patients receiving diagnostic drug susceptibility testing (DST) to 1st line drugs for MDR-TB diagnosis among people eligible for DST to 1st line as per Interim Manual "TB Control in the Penitentiary System of Azerbaijan".

  10. Number of TB patients receiving standardized 1st line treatment in penitentiary sector.

  11. Number of TB and MDR-TB (on first (f) and second (s) line treatment) patients receiving patient support (education, counseling, incentives and enablers) for better adherence to treatment in the penitentiary sector.

  12. Number of MDR-TB patients enrolled in second line treatment in penitentiary sector.

  13. Percentage and number of MDR-TB patients receiving diagnostic drug susceptibility testing (DST) to 2nd line drugs for prescription of adequate treatment regimen among people eligible to DST to 2nd line as per  Interim Manual "TB Control in the Penitentiary System of Azerbaijan".

  14. Number of patient education and counseling sessions for TB patients conducted by adherence counselors in prisons and among ex-prisoners after discharge.

  15. Number of TB doctors and nurses (d and n) in the penitentiary sector trained and re-trained in DOTS.

  16. Number of STID DR-TB department and laboratory staff trained in managerial, clinical and laboratory aspects of DR-TB management locally.